The five biggest health insurance companies in Sweden had a combined market share of over ** percent of the total market in 2016. Skandia, Sweden's leading provider of health insurance had a market share of over **** percent in 2016.

The five biggest health insurance companies in Czechia had a combined market share of ** percent of the total market in 2018. BNP Paribas, Czechia's leading provider of health insurance had a market share of approximately ** percent in 2018, more than double the share owned by second placed Generali.

In the fiscal year 2023, life insurance accounted for about **** percent of gross insurance premiums in Japan, which totaled around ***** billion U.S. dollars. This corresponded to a market share of nine percent in the OECD. Japan’s life insurance market Japan has one of the largest life insurance markets in the world. The majority of Japanese households is covered by some type of life insurance. Life insurance penetration, gross premiums written as a percentage of the GDP, stood at *** percent in fiscal year 2023, while the per capita spending on life insurance reached almost ***** U.S. dollars. The total premium income generated by private life insurers reached ** trillion yen in fiscal 2023. Life insurance providers in Japan Around ** companies are operating in Japan’s life insurance market. Nippon Life Group, Dai-ichi Life Holdings, and Meiji Yasuda Life Group are three of the largest life insurance groups in terms of premium income. In addition to companies in the private sector, there is a large number of cooperatives which offer life and health insurance products. In recent years, the emergence of so-called small amount and short-term insurance companies that offer mini insurance products has created new business opportunities in Japan's life insurance industry.

France Insuracce: Direct Premium Share to Overall Market: Life and Health data was reported at 74.200 % in 2017. This records a decrease from the previous number of 74.500 % for 2016. France Insuracce: Direct Premium Share to Overall Market: Life and Health data is updated yearly, averaging 74.200 % from Dec 1993 (Median) to 2017, with 25 observations. The data reached an all-time high of 78.300 % in 2006 and a record low of 68.800 % in 1993. France Insuracce: Direct Premium Share to Overall Market: Life and Health data remains active status in CEIC and is reported by French Federation of Insurance Companies. The data is categorized under Global Database’s France – Table FR.RG001: Insurance: Premium.

How much money does the Dutch government spend on healthcare? In 2021, the government expected to spend a total of 53.4 billion euros through the Zvw or the Health Insurance Act. This law covers the basic health insurance in the Netherlands that all residents and employees in the country are obliged to have. The numbers shown here indicate with which sources the government planned to afford this healthcare. The government expected that most money would go towards secondary care in 2019.

Health insurance in the Netherlands: two can play that game

The health system in the Netherlands has a hybrid character. The Dutch government, on the one hand, decides the contents of the mandatory basis health insurance on a yearly basis. Health insurance companies, on the other hand, have to offer this insurance as a product. They are not allowed to leave anybody out: any Dutch citizen, regardless of age or medical records, must be accepted in this insurance. The Netherlands had 11 health insurance concerns in 2019, which owned roughly 40 companies. Health insurance concern Achmea (formerly Zilveren Kruis) had a market share of approximately 30 percent, whereas the company Achmea Zorgverzekeringen N.V. had the most gross written premiums in this insurance segment.

How does the financing work exactly?

Dutch citizens have three ways to pay for the statutory health insurance, all three of which are mentioned in this statistic. First, the income related contribution (in Dutch: inkomens afhankelijke bijdrage) is a tax that is paid from one’s salary. The majority of the healthcare financing shown here was expected to come from this source: approximately 25 billion euros in 2019. Second, the nominal premium (in Dutch: nominale premie) is paid to health insurance companies and is a national average of the basic health insurance premium that the government expects these companies to use when they offer the product. The idea behind this is that free market competition forces companies to go below this average so as to curb increasing health costs (as the companies strive to make healthcare as affordable as possible in order to attract more customers). Third, the mandatory excess (in Dutch: verplichte eigen risico) is a fee the insured (18 years and older, younger ages are exempt from this) must have paid to healthcare during the year before the insurance starts to pay out. This serves the purpose of raising awareness on how expensive healthcare is.

centene.com is ranked #2016 in US with 5.64M Traffic. Categories: Healthcare, Insurance. Learn more about website traffic, market share, and more!

Over the five years through 2025-26, the General Insurance industry's revenue is forecast to grow at a compound annual rate of 2.6% to £89.3 billion, including estimated growth of 4.6% in 2025-26. After Solvency II regulations were brought in at the start of 2016, buffer requirements constricted capital. Following a solid recovery in 2021-22, the Russian invasion of Ukraine created yet more chaos in the insurance sector, especially for aviation and maritime insurance – these have been pressured by war-related risks and nervous reinsurers. At the same time, insurers have contended with claims inflation, particularly in the home and motor markets, threatening profitability. The FCA's General Insurance Pricing Practices reforms in 2022, which were restrictions on offering a renewal price that's greater than the equivalent new business price, meant insurers' ability to raise premiums to combat inflation was limited. In 2024-25, profitability was hit by persisting claims inflation and intense price competition. In 2025-26, claims pressure is set to alleviate somewhat. According to the Association of British Insurers, the average cost of motor insurance fell by £60 over the year through June 2025. However, price competition continues to erode margins as insurers lower premiums to maintain demand, resulting in profit falling to 7.1% in 2025-26. Additionally, Trump’s tariffs, although taking a less aggressive stance as previously anticipated, will keep claims costs elevated. In an attempt to protects margins in such uncertain times, insurers are turning to AI to help spot fraudulent claims, which have grown in recent years amid cost-of-living challenges and financial struggles. Over the five years through 2030-31, revenue is set to swell at a compound annual rate of 3.7% to reach £107.1 billion. Changes to the regulatory climate under the Solvency UK regulations will free up capital in the future, supporting revenue growth in the coming years. The reforms will also place a stronger emphasis on ESG factors, requiring insurers to include disclosures around green investments. Although this will draw in environmentally conscious customers, additional disclosures to lift compliance costs, stemming the jump in profit. Climate change poses a slow-moving but increasing threat as erratic weather conditions boost claim costs. However, insurers are implementing measures to support profitability, turning to AI to better assess risk, detect fraud and limit human error, optimising their claims processes.

This statistic shows the solvability of the five largest health insurance companies in the Netherlands according to Solvency II in 2015 and 2016. In 2016, the solvability ratios of four of the "big five' health insurance companies in the Netherlands decreased. This because they had to use more of their financial reserves to lower the premiums for health insurances in the Netherlands.

Solvency II is a risk-based supervisory framework from the European Commission for the insurance sector that came into effect on 1 January 2016. The Solvency II guidelines are embedded in Dutch law in the Financial Supervision Act (in Dutch: Wet op het financieel toezicht - Wft) and its subsidiary regulations. All insurance companies that are part of a group are considered as a single economic unit. Consequently, they are subject not only to individual supervision but also to supplementary group supervision.

The health insurance industry in the Netherlands is a combination of a government-based public health program and privatized health insurance concerns. The Dutch government decides on the cover provided by this package and health insurance companies are obliged to accept everyone who meets the requirements, regardless of age or state of health. In 2017, Dutch health insurance concern Zilveren Kruis had a market share of approximately ** percent.

Snapshot img { margin: 10px !important; } Market outlook of the orthopedic trauma devices market

Trauma includes severe damage to functional body components such as soft tissues, bones, nerves, and vessels. It is usually caused by an external cause such as road accidents, and major damage can lead to severe outcomes. According to WHO, every year 9% of mortality is caused because of trauma injuries across the globe. Technavio’s market research analysts estimate the global orthopedic trauma devices market to grow successfully and post a CAGR of more than 6% during the forecast period.

High prevalence of osteoarthritis and rheumatoid arthritis in the elderly population (aged 60 and above) is one of the major factors influencing the growth of the market. The aging population being more prone towards joint-related complications will increase the demand for trauma devices, thereby contributing to market growth during the forecast period. Osteoarthritis is the most common joint problem in developed countries such as the US and the UK.

Segmentation by material and analysis of - metals and non-metals

The non-metals that are most commonly used in the orthopedic trauma devices are polymers, ceramics, and composites. The use of natural polymers such as collagen, fibrin, and hyaluronic acid have resulted in good biocompatibility and osteoconductive properties. Even though these materials have low mechanical stability they are used as scaffolds for tissue engineering.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

Metals
Non-metals

Geographical segmentation and analysis of - Americas, APAC, EMEA

Technavio’s market research analysts have evaluated the Americas as the major revenue contributor to the orthopedic trauma devices market, with the US and Canada being major countries contributing to the market share. The market in the Americas will see a steady growth because the third-party payers, including domestic dealers, government, and private health insurers limit reimbursement and healthcare coverage resulting in decreased sales of new products.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

Americas
APAC
EMEA

Competitive landscape and key vendors - DePuy Synthes, Smith & Nephew, Zimmer Holding, and Stryker

The orthopedic trauma devices market is dominated by few large players and the competition among these players in the market is intense about innovation and launch of new products. Therefore, forming strategic alliances among vendors will help in penetration of a product in untapped markets as well as expansion of product portfolio and increased product sales, thus gaining substantial market shares.

The top vendors in this market are -

DePuy Synthes
Smith & Nephew
Zimmer Holding
Stryker

Other prominent vendors included in this report are AAP Implantate, Acumed, Arthrex, Arthrosurface, Cardinal Health, Ellipse Technologies, Flower Orthopedics, Orthopaedic Innovation, Medartis, Nextremity, Solutions, Osteomed, Paragon 28, Skeletal Dynamics, Tornier, Tyber Medical, Virak Orthopedic, and Wright Medical.

Key questions answered in the report include

What will the orthopedic trauma devices size and the growth rate be in 2020?
What are the key factors driving the global orthopedic trauma devices market?
What are the key orthopedic trauma devices trends impacting the growth of the market?
What are the challenges to market growth?
Who are the key vendors in the global orthopedic trauma devices?
What are the market opportunities and threats faced by the vendors in the global orthopedic trauma devices?
What are the trending factors influencing the market shares of the APAC, EMEA, and the Americas?
What are the key outcomes of the five forces analysis of the global orthopedic trauma devices?

Technavio also offers customization on reports based on specific client requirement.

Related reports

Global Coronary Artery Disease Treatment Devices Market 2015-2019
Global Geriatric Care Devices Market 2015-2019
Global COPD and Asthma Devices Market - Industry Analysis 2015-2019
Global Medical Disposable Gloves Market 2015-2019
Global Medical Device Manufacturing Services Outsourcing Market 2014-2018

In fiscal year 2020, health insurers in India collected a total health insurance premium of over *** billion Indian rupees. Stand-alone health insurers nearly tripled their premium amounts to over *** billion Indian rupees in fiscal year 2020 compared to 2016. While the private sector general insurers doubled their size to over *** billion Indian rupees from 2016 to 2020, the public sector general insurers led the market with premium amounts of over *** billion Indian rupees during the same time period.

Emergency and outpatient care centers have developed a fast-growing role in healthcare delivery in the United States. While rising incomes and broader insurance coverage have facilitated access to outpatient care in recent years, rising healthcare costs, declining reimbursements and tech advances have moved more procedures to the outpatient setting. The shift to outpatient care has continued since the pandemic in 2020, and outpatient care centers are treating more patients than ever as same-day care offers patients valuable convenience, safety and cost-savings over the hospital setting. While most outpatient providers continue to navigate financial challenges and labor issues, profit remains strong, having seen significant growth as patient volumes climb. Industry revenue has been expanding at a CAGR of 1.6% to $215.8 billion in 2025, including expected growth of 2.1% in 2025 alone. Freestanding emergency departments and ambulatory surgery centers (ASCs) are two of the fastest-growing areas in outpatient care. Combined, freestanding ambulatory surgical and emergency centers' revenue increased at a CAGR of 8.0% from 2016 to 2022. In second place was Other Outpatient Care Centers, which saw a CAGR of 6.0% for the same period. Private equity investment is entering the space, supporting investment in ASCs and expansion by hospitals to enter this market, demonstrating the increased demand. However, other outpatient centers (HMO medical centers, kidney dialysis centers) have grown more slowly. Moving forward, more patients will seek care at alternative care sites. ASCs support the shift from inpatient to outpatient by delivering lower costs with better outcomes. Rising healthcare costs and an aging population will also drive the need for cost-effective, accessible care, making outpatient settings more attractive for various medical services. To meet this demand, telehealth and AI tools are significantly enhancing profitability for emergency outpatient care centers by reducing operational costs through automated administrative systems, optimizing resource allocation and improving diagnostic accuracy. But accessibility to state-of-the-art AI and technology may be out of reach for smaller care centers. The One Big Beautiful Bill Act (OBBBA) poses severe revenue threats to outpatient care centers through a 15.0% reduction in Medicaid spending and 2.8% cuts in Medicare physician payment rates, potentially causing 15.0-30.0% revenue declines for facilities dependent on government reimbursements. Despite the various cost and funding challenges and technology-based opportunities, industry revenue is expected to gain at a CAGR of 2.7% to $246.2 billion in 2030, with profit dropping slightly to 14.6% of revenue.

Zilveren Kruis Achmea's health division was the largest Dutch insurance company in 2022, with just over ** billion euros worth of gross written premiums. The first **** entries in this ranking were all health or life insurance companies, with only the ***** ranking (Achmea Schade) being a company that focuses on property and casualty insurance. Health insurance companies tend to be the biggest insurance companies of the country, sometimes having more than *** million policy holders.

Why are the numbers provided per branch, and not for the company as a whole?

Insurance companies in the Netherlands each have multiple branches that operate separately from one another. This, among other reasons, has to do with how health insurance is set up in the country. Simply put, the Dutch government decides the content of the national health insurance (which every Dutch resident must get). It is the private market, however, which rolls this out and sets the prices. The Dutch health authority, then, checks the financial status of the companies. Statista offers a ranking which solely looks at the revenue of health insurance companies in the Netherlands and describes in more detail how this system works.

Financial results of the Dutch insurance market

The technical results of Dutch insurance branches, as a percentage of the gross earned premiums, were under pressure in 2019. Due to the artificially low interest rates of the European Central Bank's (ECB) monetary policy, Dutch insurance companies struggled to make profits, as their investments become less valuable. Also, they had to compensate more money to their insured, for example because of damage due to extreme weather conditions or the ageing of the population. However, most insurance sectors had more favorable technical results by 2021.

This statistic shows the distribution of expenditure of health insurance companies in Norway in 2016, by service. Surgeries, specialist doctors/diagnostics and physical therapies/chiropractics accounted for the majority of treatments that health insurances defrayed the costs. Surgeries had a share of ** percent, while specialist doctors/diagnostics had a share of ** percent. The expenditure for physical therapy/chiropractics had a share of ** percent.

This statistic shows a breakdown of advertising costs per customer of individual health insurance companies in the Netherlands as of 2017. Health insurance in the Netherlands combines elements of both public as well as private insurance. The Netherlands has **** big health insurance concerns in the Netherlands (*** since early 2018), each with multiple companies. As of 2018, there are ** health insurance companies. Some of those companies also have multiple brands.

It is mandatory to have at least a basic health insurance (in Dutch: basisverzekering) when you work in the Netherlands, because healthcare is funded through taxation of income. Because of this, health insurers have to publicly publish information on, for example, advertising costs.

In 2017, ENO was the insurer which spent ***** euros per customer on advertising costs. This is higher than the average advertising costs per customer in 2016, when health insurance companies roughly spent **** euros per customer on advertising. The concern ENO, to which the company ENO belongs, had a market share of *** percent in 2018.

保险：直接保费占全部市场的份额：人寿保险和健康保险在12-01-2017达74.200%，相较于12-01-2016的74.500%有所下降。保险：直接保费占全部市场的份额：人寿保险和健康保险数据按年更新，12-01-1993至12-01-2017期间平均值为74.200%，共25份观测结果。该数据的历史最高值出现于12-01-2006，达78.300%，而历史最低值则出现于12-01-1993，为68.800%。CEIC提供的保险：直接保费占全部市场的份额：人寿保险和健康保险数据处于定期更新的状态，数据来源于FFSA, Federation Francaise des Societes d’Assurances，数据归类于Global Database的法国 – 表 RG.FR001：保险：保费。

In the fiscal year 2024, the New India Assurance Company held a market share of around ** percent based on the gross direct premium underwritten by non-life insurers in India. Following closely was ICICI Lombard General Insurance Company, with a market share of **** percent. Among the standalone health insurers, Star Health and Allied Insurance led the segment, capturing over **** percent of the market share.

This statistic shows the result of a survey on the share of individuals with dog insurance in Denmark in 2016, by insurance type. The majority of the surveyed dog owners stated to have a liability insurance. ** percent of respondents had a health insurance for their pets, while ** percent had a life insurance.

This statistic shows the share of companies that offer health coverage to opposite-sex domestic partners in the United States in 2016, by industry. It was found that ** percent of retail companies offered health coverage to opposite-sex domestic partners.

In 2023, the total expenditure on health care in China reached over ************* yuan. That figure included government spending, collective spending, and private out-of-pocket spending on health care. Health expenditures worldwide The health expenditure in China has soared from under *********** yuan in 2000 to more than ************* in 2023. The reasons behind this growth are multifold. Most important factors are the increasing living standards and the aging of the population. In terms of relative numbers, health expenditure as a proportion of Gross Domestic Product (GDP) has also been increasing in general in the last two decades and reached over *** percent in recent years. This indicates the growing importance the government attributed to the health care in the country. However, this is still a relatively low share of GDP when compared to other more developed countries, for example Australia or South Korea. Health care in China The same phenomenon is reflected in the increase in private per capita health expenditure of Chinese households as well, which has nearly tripled in the last decade for Beijing, as the region with the highest private health expenditure in China. Health insurance is voluntary in China, but the share of the population being covered by a basic health insurance has grown quickly in the last ten years. In 2017, the number of people covered by basic health insurance surpassed *********** for the first time. In 2019, more than ** percent of the population enjoyed at least a basic health insurance. Additional commercial health insurances were especially purchased by people working as executives or professionals.

In 2023, U.S. national health expenditure as a share of its gross domestic product (GDP) reached 17.6 percent, this was an increase on the previous year. The United States has the highest health spending based on GDP share among developed countries. Both public and private health spending in the U.S. is much higher than other developed countries. Why the U.S. pays so much moreWhile private health spending in Canada stays at around three percent and in Germany under two percent of the gross domestic product, it is nearly nine percent in the United States. Another reason for high costs can be found in physicians’ salaries, which are much higher in the U.S. than in other wealthy countries. A general practitioner in the U.S. earns nearly twice as much as the average physician in other high-income countries. Additionally, medicine spending per capita is also significantly higher in the United States. Finally, inflated health care administration costs are another of the predominant factors which make health care spending in the U.S. out of proportion. It is important to state that Americans do not pay more because they have a higher health care utilization, but mainly because of higher prices. Expected developmentsBy 2031, it is expected that health care spending in the U.S. will reach nearly one fifth of the nation’s gross domestic product. Or in dollar-terms, health care expenditures will accumulate to about seven trillion U.S. dollars in total.